Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 5/20 | 0.41 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.41 |
| ▸ | CCR5 | P51681 | 5/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.39 |
| ▸ | HTR1A | P08908 | 1/20 | 0.38 |
| ▸ | DRD2 | P14416 | 1/20 | 0.38 |
| ▸ | HTR2A | P28223 | 1/20 | 0.38 |
| ▸ | HTR7 | P34969 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL768952 | 0.85 | OPRM1 (0.44) | OPRM1POLBOPRD1DRD2 | |
| SCHEMBL769137 | 0.84 | OPRD1 (0.43) | OPRM1POLBOPRD1DRD2 | |
| SCHEMBL768532 | 0.84 | OPRM1 (0.43) | OPRM1POLBOPRD1 | |
| SCHEMBL767766 | 0.84 | OPRM1 (0.43) | OPRM1POLBOPRD1 | |
| SCHEMBL768639 | 0.83 | OPRD1 (0.44) | OPRM1OPRD1 | |
| Hydrochloric Acid SCHEMBL768804 | 0.82 | OPRD1 (0.43) | OPRM1POLBOPRD1 | |
| SCHEMBL768618 | 0.82 | OPRM1 (0.41) | OPRM1POLBOPRD1DRD2 | |
| SCHEMBL768102 | 0.81 | OPRM1 (0.41) | OPRM1OPRD1 | |
| SCHEMBL768734 | 0.81 | POLB (0.43) | OPRM1POLBHTR1ADRD2HTR2A | |
| SCHEMBL381421 | 0.79 | CHRM3 (0.64) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120071467-A1 | AMIDE DERIVATIVE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2012-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120071467-A1 | AMIDE DERIVATIVE | CHRM3, CHRM2, TACR2 | OPRM1 15/4885OPRL1 65/4885CCR5 844/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.